Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FR.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FR.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FR.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FR.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FR.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
FL.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-18682.1Germany
FL.2.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.2.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-21537China
FL.2.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.2.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16900.3China
FL.2.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.25ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.25ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.33ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
MH.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MH.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
LB.1.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.3.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.3.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
LB.1.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
LB.1.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-2902.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used